Takhzyro

Takhzyro Indications/Uses

lanadelumab

Manufacturer:

Takeda

Distributor:

Zuellig Pharma

Marketer:

Takeda

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing Local Product Insert

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Indications/Uses

TAKHZYRO is indicated for routine prevention of recurrent attacks of hereditary angioedema (HAE) in patients aged 12 years and older.

Sign up for Free to Continue Reading

Continue with Google

Sign Up With Email

Already a member? Sign In